Junjie Zhu

3.5k total citations · 3 hit papers
71 papers, 2.6k citations indexed

About

Junjie Zhu is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Junjie Zhu has authored 71 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Biomedical Engineering. Recurrent topics in Junjie Zhu's work include Nanoplatforms for cancer theranostics (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Junjie Zhu is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Junjie Zhu collaborates with scholars based in China, United States and Spain. Junjie Zhu's co-authors include Yang Yang, Hongjie Zhang, Yinghui Wang, Longhai Jin, Xiaochao Ma, Shuyan Song, Min Xu, Xiuyun Jiang, Lei Kong and Zengfen Pang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Junjie Zhu

68 papers receiving 2.6k citations

Hit Papers

One‐Dimensional Fe2P Acts as a Fenton Agent in Response t... 2019 2026 2021 2023 2019 2025 2025 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjie Zhu China 25 1.1k 889 592 506 292 71 2.6k
Meixiao Zhan China 33 1.2k 1.2× 852 1.0× 349 0.6× 625 1.2× 396 1.4× 115 3.1k
Xiaoge Zhang China 27 850 0.8× 1.0k 1.1× 537 0.9× 237 0.5× 265 0.9× 87 2.5k
Yan Ma China 31 1.8k 1.7× 710 0.8× 369 0.6× 992 2.0× 289 1.0× 85 3.4k
Xue Yang China 30 1.3k 1.2× 688 0.8× 264 0.4× 614 1.2× 408 1.4× 156 3.2k
Yunsheng Xu China 27 1.1k 1.0× 685 0.8× 299 0.5× 351 0.7× 261 0.9× 70 2.6k
Yuan Ding China 24 1.0k 0.9× 1.3k 1.5× 563 1.0× 257 0.5× 319 1.1× 90 2.8k
Xiaowei Ma China 27 1.2k 1.1× 607 0.7× 480 0.8× 229 0.5× 182 0.6× 104 2.6k
Xiaoyan Lv China 28 1.3k 1.2× 743 0.8× 546 0.9× 224 0.4× 126 0.4× 96 3.2k
Qing Zhou China 32 1.4k 1.3× 1.1k 1.2× 293 0.5× 306 0.6× 232 0.8× 101 3.2k

Countries citing papers authored by Junjie Zhu

Since Specialization
Citations

This map shows the geographic impact of Junjie Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjie Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjie Zhu more than expected).

Fields of papers citing papers by Junjie Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjie Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjie Zhu. The network helps show where Junjie Zhu may publish in the future.

Co-authorship network of co-authors of Junjie Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Junjie Zhu. A scholar is included among the top collaborators of Junjie Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjie Zhu. Junjie Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fei, Xiang, Bin Zhou, Qing Xia, et al.. (2025). Hemoglobin‐Mediated Dual‐Crosslinked Silk Fibroin With Enhanced Elasticity, Rigidity, Toughness, and Shapeability for Tracheal Tissue Application. Advanced Functional Materials. 35(36). 2 indexed citations
3.
Fang, Huapan, Junjie Zhu, Zhiqiang Wu, et al.. (2025). Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis. ACS Nano. 19(2). 2742–2758. 13 indexed citations breakdown →
4.
Liu, Yuqing, Shiling Zhang, Kai Jiang, et al.. (2024). Near-infrared light responsive upconversion-DNA nanocapsules for remote-controlled CRISPR-Cas9 genome editing. Chinese Chemical Letters. 36(5). 110282–110282. 1 indexed citations
5.
Zhang, Ruiyun, Junjie Zhu, Di Jin, et al.. (2024). Strategically Staged Tumor Ablation and Inflammation Suppression Using Shell‐Core Nanoparticles to Eradicate Bladder Tumors and Prevent Recurrence. Advanced Functional Materials. 34(37). 5 indexed citations
6.
Zhu, Junjie, Fu‐Ying Qin, Saifei Lei, et al.. (2024). Inhibition of ABCG2 prevents phototoxicity in a mouse model of erythropoietic protoporphyria. Nature Communications. 15(1). 10557–10557. 1 indexed citations
7.
Liu, Zhengxiang, et al.. (2023). Molecular detection of Bartonella species in wild small mammals in western Yunnan Province, China. Frontiers in Veterinary Science. 10. 1301316–1301316. 2 indexed citations
8.
Liu, Yang, Rui Shao, Tongchuan Suo, et al.. (2023). Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway. Journal of Ethnopharmacology. 309. 116354–116354. 6 indexed citations
9.
Liu, Sitong, et al.. (2023). Orientia tsutsugamushi Infection in Wild Small Mammals in Western Yunnan Province, China. Pathogens. 12(1). 128–128. 6 indexed citations
10.
11.
Liu, Yang, et al.. (2022). Single‐Atom Nanozyme with Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis. Advanced Materials. 35(9). e2208512–e2208512. 121 indexed citations
12.
Xu, Pengfei, Yue Xi, Junjie Zhu, et al.. (2021). Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis. Gastroenterology. 161(1). 271–286.e11. 42 indexed citations
13.
Wang, Hao, Shanhao Chen, Chunyan Wu, et al.. (2021). Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma. OncoTargets and Therapy. Volume 14. 2953–2965. 9 indexed citations
14.
Yu, Yuting, Qi Zhao, Yonggen Jiang, et al.. (2021). Association of the Reproductive Period with Decreased Estimated Glomerular Filtration Rate in Menopausal Women: A Study from the Shanghai Suburban Adult Cohort and Biobank (2016–2020). International Journal of Environmental Research and Public Health. 18(19). 10451–10451. 5 indexed citations
15.
Zhu, Junjie, et al.. (2021). Alterations of Cytochrome P450–Mediated Drug Metabolism during Liver Repair and Regeneration after Acetaminophen-Induced Liver Injury in Mice. Drug Metabolism and Disposition. 50(5). 694–703. 18 indexed citations
16.
Wang, Qishun, Huan Wang, Yang Yang, et al.. (2019). Plasmonic Pt Superstructures with Boosted Near‐Infrared Absorption and Photothermal Conversion Efficiency in the Second Biowindow for Cancer Therapy. Advanced Materials. 31(46). e1904836–e1904836. 136 indexed citations
17.
Liu, Yang, Wenyao Zhen, Yinghui Wang, et al.. (2019). One‐Dimensional Fe2P Acts as a Fenton Agent in Response to NIR II Light and Ultrasound for Deep Tumor Synergetic Theranostics. Angewandte Chemie. 131(8). 2429–2434. 52 indexed citations
18.
Liu, Yang, Wenyao Zhen, Yinghui Wang, et al.. (2019). One‐Dimensional Fe2P Acts as a Fenton Agent in Response to NIR II Light and Ultrasound for Deep Tumor Synergetic Theranostics. Angewandte Chemie International Edition. 58(8). 2407–2412. 351 indexed citations breakdown →
19.
Yu, Pengfei, Shiqi Wang, Zhaoyan Qiu, et al.. (2016). Efficacy of resistin and leptin in predicting persistent organ failure in patients with acute pancreatitis. Pancreatology. 16(6). 952–957. 14 indexed citations
20.
Kong, Lei, Junjie Zhu, Wenxia Han, et al.. (2010). Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetologica. 48(1). 61–69. 439 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026